Literature DB >> 1551940

Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients.

J Briolay1, J Dechanet, D Blanchard, J Banchereau, P Miossec.   

Abstract

Rheumatoid arthritis (RA) is associated with T- and B-cell dysfunction. Immunoglobulin (Ig) production is under the control of T cells and their derived cytokines such as interleukin 2 (IL-2) and IL-4. Herein we studied the regulation of the production of immunoglobulins and cytokines by peripheral blood mononuclear cells from RA patients and controls. In the controls, IL-4 inhibited Ig production in response to Staphylococcus aureus and pokeweed mitogen stimulation. IL-2 induced maximal Ig production in association with Staphylococcus aureus, whereas it inhibited pokeweed mitogen-induced production. In patients, levels of Ig production in response to mitogens and cytokines were reduced, particularly for the response to IL 2. The inhibitory effect of IL-4 on mitogen-induced Ig production was observed in RA patients as in the controls. Spontaneous production of IL-6 was increased in RA patients. These levels were correlated with indicators of active disease such as sedimentation rate and Ritchie index. IL-4 inhibited the production of IL-6, IL-1 beta, and tumor necrosis factor alpha (TNF alpha) by both controls and rheumatoid patients. Thus as first described for the T-cell response, mononuclear cells from RA patients display a reduced response to mitogens and cytokines which induce their B-cell differentiation into Ig-screening cells. However, IL-4 was able to inhibit Ig and cytokine production, properties suggesting a potential antiinflammatory role for this cytokine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551940     DOI: 10.1007/bf00918271

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.

Authors:  O M Martinez; R S Gibbons; M R Garovoy; F R Aronson
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

Review 3.  Regulation of human B lymphocyte activation, proliferation, and differentiation.

Authors:  D F Jelinek; P E Lipsky
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

4.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

5.  Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis.

Authors:  P Miossec; M Naviliat; A Dupuy d'Angeac; J Sany; J Banchereau
Journal:  Arthritis Rheum       Date:  1990-08

6.  Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation.

Authors:  M E Hemler; D Glass; J S Coblyn; J G Jacobson
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes.

Authors:  D L Cheung; P H Hart; G F Vitti; G A Whitty; J A Hamilton
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

8.  Induction of immunoglobulin synthesis by interleukin 2 is T4+/T8- cell dependent. A role for interleukin 2 in the pokeweed mitogen-driven system.

Authors:  F Miedema; J W Van Oostveen; R W Sauerwein; F G Terpstra; L A Aarden; C J Melief
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

9.  Role of IL-2 in the generation of CD4+ suppressors of human B cell responsiveness.

Authors:  S Hirohata; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

10.  Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis.

Authors:  G S Firestein; W D Xu; K Townsend; D Broide; J Alvaro-Gracia; A Glasebrook; N J Zvaifler
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  4 in total

1.  Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis.

Authors:  F M Cicuttini; K A Byron; D Maher; A M Wootton; K D Muirden; J A Hamilton
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

2.  Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts.

Authors:  J F Schlaak; A Schwarting; P Knolle; K H Meyer zum Büschenfelde; W Mayet
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

3.  Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4.

Authors:  J A van Roon; J L van Roy; A Duits; F P Lafeber; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

4.  Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide.

Authors:  Sarah E Wythe; Danielle DiCara; Taher E I Taher; Ciara M Finucane; Rita Jones; Michele Bombardieri; Y K Stella Man; Ahuva Nissim; Stephen J Mather; Yuti Chernajovsky; Costantino Pitzalis
Journal:  Ann Rheum Dis       Date:  2012-07-27       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.